Ann Pediatr Endocrinol Metab.  2024 Feb;29(1):38-45. 10.6065/apem.2346036.018.

Genetic evaluation using next-generation sequencing of children with short stature: a single tertiary-center experience

• Kim SJ
• Joo E
• Park J
• Seol CA
• Lee JE

• KMID: 2553016
• DOI: http://doi.org/10.6065/apem.2346036.018

Abstract

Purpose
We used next-generation sequencing (NGS) to investigate the genetic causes of suspected genetic short stature in 37 patients, and we describe their phenotypes and various genetic spectra.
Methods
We reviewed the medical records of 50 patients who underwent genetic testing using NGS for suspected genetic short stature from June 2019 to December 2022. Patients with short stature caused by nongenetic factors or common chromosomal abnormalities were excluded. Thirty-seven patients from 35 families were enrolled in this study. We administered one of three genetic tests (2 targeted panel tests or whole exome sequencing) to patients according to their phenotypes.
Results
Clinical and molecular diagnoses were confirmed in 15 of the 37 patients, for an overall diagnostic yield of 40.5%. Fifteen pathogenic/likely pathogenic variants were identified in 13 genes (ACAN, ANKRD11, ARID1B, CEP152, COL10A1, COL1A2, EXT1, FGFR3, NIPBL, NRAS, PTPN11, SHOX, SLC16A2). The diagnostic rate was highest in patients who were small for their gestational age (7 of 11, 63.6%).
Conclusion
Genetic evaluation using NGS can be helpful in patients with suspected genetic short stature who have clinical and genetic heterogeneity. Further studies are needed to develop patient selection algorithms and panels containing growth-related genes.

Keyword

Dwarfism; Growth hormone; Next-generation sequencing

Reference

References

1. Quitmann JH, Bullinger M, Sommer R, Rohenkohl AC, Bernardino Da Silva NM. Associations between psychological problems and quality of life in pediatric short stature from patients' and parents' perspectives. PLoS One. 2016; 11:e0153953.

2. McEvoy BP, Visscher PM. Genetics of human height. Econ Hum Biol. 2009; 7:294–306.

3. Dauber A, Rosenfeld RG, Hirschhorn JN. Genetic evaluation of short stature. J Clin Endocrinol Metab. 2014; 99:3080–92.

4. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014; 46:1173–86.

5. Hirschhorn JN, Lettre G. Progress in genome-wide association studies of human height. Horm Res. 2009; 71 Suppl 2:5–13.

6. Li X, Yao R, Chang G, Li Q, Song C, Li N, et al. Clinical profiles and genetic spectra of 814 Chinese children with short stature. J Clin Endocrinol Metab. 2022; 107:972–85.

7. Costantini A, Muurinen MH, Makitie O. New gene discoveries in skeletal diseases with short stature. Endocr Connect. 2021; 10:R160–74.

8. Hauer NN, Popp B, Schoeller E, Schuhmann S, Heath KE, Hisado-Oliva A, et al. Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature. Genet Med. 2018; 20:630–8.

9. Ahn J, Oh J, Suh J, Song K, Kwon A, Chae HW, et al. Nextgeneration sequencing-based mutational analysis of idiopathic short stature and isolated growth hormone deficiency in Korean pediatric patients. Mol Cell Endocrinol. 2022; 544:111489.

10. Fan X, Zhao S, Yu C, Wu D, Yan Z, Fan L, et al. Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature. J Genet Genomics. 2021; 48:396–402.

11. Yang L, Zhang C, Wang W, Wang J, Xiao Y, Lu W, et al. Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted nextgeneration sequencing panel. BMC Med Genet. 2018; 19:212.

12. Huang Z, Sun Y, Fan Y, Wang L, Liu H, Gong Z, et al. Genetic evaluation of 114 Chinese short stature children in the next generation era: a single center study. Cell Physiol Biochem. 2018; 49:295–305.

13. Kim YM, Lee YJ, Park JH, Lee HD, Cheon CK, Kim SY, et al. High diagnostic yield of clinically unidentifiable syndromic growth disorders by targeted exome sequencing. Clin Genet. 2017; 92:594–605.

14. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018; 61:135–49.

15. Lee JK, Jang HL, Kang BH, Lee KS, Choi YS, Shim KS, et al. Percentile Distributions of Birth Weight according to Gestational Ages in Korea (2010-2012). J Korean Med Sci. 2016; 31:939–49.

16. Hyun SE, Lee BC, Suh BK, Chung SC, Ko CW, Kim HS, et al. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents. Clin Biochem. 2012; 45:16–21.

17. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–24.

18. Seo GH, Kim T, Choi IH, Park JY, Lee J, Kim S, et al. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE. Clin Genet. 2020; 98:562–70.

19. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020; 22:245–57.

20. McCormick EM, Lott MT, Dulik MC, Shen L, Attimonelli M, Vitale O, et al. Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation. Hum Mutat. 2020; 41:2028–57.

21. Sentchordi-Montane L, Benito-Sanz S, Aza-Carmona M, Diaz-Gonzalez F, Modamio-Hoybjor S, de la Torre C, et al. High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies. Eur J Endocrinol. 2021; 185:691–705.

22. Guo MH, Shen Y, Walvoord EC, Miller TC, Moon JE, Hirschhorn JN, et al. Whole exome sequencing to identify genetic causes of short stature. Horm Res Paediatr. 2014; 82:44–52.

23. Wit JM, Oostdijk W, Losekoot M, van Duyvenvoorde HA, Ruivenkamp CA, Kant SG. Mechanisms in endocrinology: novel genetic causes of short stature. Eur J Endocrinol. 2016; 174:R145–73.

24. Andrade AC, Jee YH, Nilsson O. New genetic diagnoses of short stature provide insights into local regulation of childhood growth. Horm Res Paediatr. 2017; 88:22–37.

25. Nilsson O, Guo MH, Dunbar N, Popovic J, Flynn D, Jacobsen C, et al. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J Clin Endocrinol Metab. 2014; 99:E1510–8.

26. Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002; 87:1402–6.

27. Finken MJJ, van der Steen M, Smeets CCJ, Walenkamp MJE, de Bruin C, Hokken-Koelega ACS, et al. Children born small for gestational age: differential diagnosis, molecular genetic evaluation, and implications. Endocr Rev. 2018; 39:851–94.

28. Netchine I, van der Steen M, Lopez-Bermejo A, Koledova E, Maghnie M. New horizons in short children born small for gestational age. Front Pediatr. 2021; 9:655931.